Decision Intelligence for Regulated Commercial Teams
Upstream risk review and planning support before MLR, rework, and escalation.
Strategic Growth AI helps regulated life-sciences teams identify risk earlier, reduce avoidable friction, and make better decisions while there is still time to adjust, without replacing expert judgment or formal review.
🟦 OmniVynt™
Marketing Risk Review (Pre-MLR)
Helps marketing and commercial teams pre-screen what they can say using jurisdiction-specific promotional expectations, before content is built, briefed to agencies, or submitted for medical, legal review.
What it enables
-
Flags promotional risk early
-
Suggests compliant alternatives, not just rejections
-
Reduces agency rework and late-stage escalation
-
Improves first-pass submission quality
-
Accelerates time to market
Primary users: Marketing, Brand, Commercial Excellence
Jurisdiction focus: Canada
🟩 RegVynt™
Early Risk Detection for Regulated Content
Enable compliance and medical teams to operationalize defensible review across activities, venues, and programs upstream of formal systems.
What it enables
-
Detects repeat-pattern compliance risk early
-
Improves consistency and audit defensibility
-
Reduces avoidable revisions and reviewer burden
-
Preserves full human oversight (no auto-approval)
Primary users: Compliance, Medical, Regulatory
Also supports: Commercial, Marketing, Market Access & Operations by reducing rework, improving predictability, and accelerating time to market
Jurisdiction focus: Canada
How They Work Together
OmniVynt helps teams decide what’s safe to build.
RegVynt helps teams govern what gets approved.
Both operate upstream of formal review systems, supporting faster, cleaner execution without replacing expert judgment.